Michael P. Lux

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis et al. · The American Journal of Human Genetics · 2018 · 1.1K citations · Full text

Cognitive function during neoadjuvant chemotherapy for breast cancer

Kerstin Hermelink, Michael Untch, Michael P. Lux et al. · Cancer · 2007 · 352 citations · Full text

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

Peter A. Fasching, Katharina Heusinger, Lothar Haeberle et al. · BMC Cancer · 2011 · 322 citations · Full text

Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection

Michael Schrauder, Reiner Strick, Rüdiger Schulz‐Wendtland et al. · PLoS ONE · 2012 · 250 citations · Full text

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

Nadia Harbeck, Manfred Schmitt, Christoph Meisner et al. · European Journal of Cancer · 2013 · 163 citations

Ten-year Analysis, Breast Oncology, Medicine +9